Literature DB >> 33407704

Factors affecting the incidence of postoperative periprosthetic fractures following primary and revision hip arthroplasty: a systematic review and meta-analysis.

Christos Bissias1, Angelos Kaspiris2, Athanasios Kalogeropoulos3, Konstantinos Papoutsis4, Nikolaos Natsioulas4, Konstantinos Barbagiannis4, Panayiotis J Papagelopoulos5, Olga D Savvidou5.   

Abstract

OBJECTIVES: The increasing number of hip arthroplasties (HA), due to the growing elderly population, is associated with the risk of femoral periprosthetic fractures (FPFs). The purpose of this study was to identify potential risk factors for the development of FPFs after HA.
METHODS: A systematic review was conducted in five data bases (Medline, Embase, Cochrane, Cinahl, ICTRP) according to the Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) guidelines up to May 2019, using the key words "risk factor," "periprosthetic fracture," and "hip replacement or arthroplasty." Meta-analysis of the clinical outcomes of HA and subgroup analysis based on the factors that were implicated in FPFs was performed.
RESULTS: Sixteen studies were included (sample size: 599,551 HA patients, 4253 FPFs, incidence 0.71%). Risk factors statistically associated with increased incidence of FPFs were female gender (+ 40%), previous revision arthroplasty surgery (× 3 times), and the presence of rheumatoid arthritis (× 2.1 times), while osteoarthritis (- 57%), cement application (- 59%), and insertion of Biomet (- 68%) or Thompson's prosthesis (- 75%) were correlated with low prevalence of FPFs. Obesity, cardiac diseases, advanced age, bad general health (ASA grade ≥ 3), and use of Exeter or Lubinus prosthesis were not linked to the appearance of FPFs.
CONCLUSION: This meta-analysis suggested that female gender, rheumatoid arthritis, and revision arthroplasty are major risk factors for the development of FPFs after a HA. In those patients, frequent follow-ups should be planned. Further prospective studies are necessary to clarify all the risk factors contributing to the appearance of FPFs after HA.

Entities:  

Keywords:  Hip arthroplasty; Periprosthetic fractures; Risk factors

Mesh:

Substances:

Year:  2021        PMID: 33407704      PMCID: PMC7788804          DOI: 10.1186/s13018-020-02152-0

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  52 in total

1.  Interobserver and intraobserver reliability and validity of the Vancouver classification system of periprosthetic femoral fractures after hip arthroplasty.

Authors:  Gohar A Naqvi; Shakoor A Baig; Nasir Awan
Journal:  J Arthroplasty       Date:  2012-03-14       Impact factor: 4.757

Review 2.  Periprosthetic femoral fractures in total hip arthroplasty - a review.

Authors:  Faizal Rayan; Fares Haddad
Journal:  Hip Int       Date:  2010 Oct-Dec       Impact factor: 2.135

Review 3.  Incidence and predisposing factors of periprosthetic proximal femoral fractures: a literature review.

Authors:  Claudia C Sidler-Maier; James P Waddell
Journal:  Int Orthop       Date:  2015-03-27       Impact factor: 3.075

4.  Periprosthetic femoral fracture within two years after total hip replacement: analysis of 437,629 operations in the nordic arthroplasty register association database.

Authors:  Truike M Thien; Georgios Chatziagorou; Göran Garellick; Ove Furnes; Leif I Havelin; Keijo Mäkelä; Søren Overgaard; Alma Pedersen; Antti Eskelinen; Pekka Pulkkinen; Johan Kärrholm
Journal:  J Bone Joint Surg Am       Date:  2014-10-01       Impact factor: 5.284

Review 5.  Epidemiology: hip and knee.

Authors:  D J Berry
Journal:  Orthop Clin North Am       Date:  1999-04       Impact factor: 2.472

6.  The risk of peri-prosthetic fracture after primary and revision total hip and knee replacement.

Authors:  R M D Meek; T Norwood; R Smith; I J Brenkel; C R Howie
Journal:  J Bone Joint Surg Br       Date:  2011-01

7.  Young age and wedge stem design are risk factors for periprosthetic fracture after arthroplasty due to hip fracture. A case-control study.

Authors:  Roope Sarvilinna; Heini Huhtala; Jorma Pajamäki
Journal:  Acta Orthop       Date:  2005-02       Impact factor: 3.717

8.  Prevalence of Total Hip and Knee Replacement in the United States.

Authors:  Hilal Maradit Kremers; Dirk R Larson; Cynthia S Crowson; Walter K Kremers; Raynard E Washington; Claudia A Steiner; William A Jiranek; Daniel J Berry
Journal:  J Bone Joint Surg Am       Date:  2015-09-02       Impact factor: 5.284

9.  Epidemiology of periprosthetic femoral fractures in 5417 revision total hip arthroplasties: a 40-year experience.

Authors:  M P Abdel; M T Houdek; C D Watts; D G Lewallen; D J Berry
Journal:  Bone Joint J       Date:  2016-04       Impact factor: 5.082

10.  Atypical femoral neck fracture after prolonged bisphosphonate therapy.

Authors:  Kwang-Kyoun Kim; Young-Wook Park; Tae-Hyeong Kim; Kyung-Deok Seo
Journal:  J Pathol Transl Med       Date:  2020-06-29
View more
  4 in total

Review 1.  Narrative Review of the Mechanism of Hip Prosthesis Dislocation and Methods to Reduce the Risk of Dislocation.

Authors:  Maciej Kostewicz; Grzegorz Szczęsny; Wiesław Tomaszewski; Paweł Małdyk
Journal:  Med Sci Monit       Date:  2022-06-18

2.  Revision Total Hip Arthroplasty with Primary Stem or Full-Porous-Coated Long Stem for Aseptic Femoral Component Loosening: A Matched-Pair Study.

Authors:  Meng-Huan Tsai; Chun-Chieh Chen; Chih-Hsiang Chang; Yuhan Chang; Pang-Hsin Hsieh; Chih-Chien Hu
Journal:  Orthop Res Rev       Date:  2022-02-15

3.  Should age be a factor in treatment choice of periprosthetic Vancouver B2-B3 proximal femur fractures? A retrospective analysis of mortality and functional outcomes in elderly patients.

Authors:  Gianluca Canton; Nicholas Rasio; Mauro Garlatti; Chiara Ratti; Anže Kristan; Luigi Murena
Journal:  Acta Biomed       Date:  2022-03-10

4.  Factors influencing results and complications in proximal periprosthetic femoral fractures: a retrospective study at 1- to 8-year follow-up.

Authors:  Chiara Concina; Marina Crucil; Franco Gherlinzoni
Journal:  Acta Biomed       Date:  2021-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.